Actively Recruiting
Improving Nighttime Access to Care and Treatment; Part 4-Haiti
Led by University of Florida · Updated on 2025-06-30
7124
Participants Needed
1
Research Sites
257 weeks
Total Duration
On this page
Sponsors
U
University of Florida
Lead Sponsor
F
Fogarty International Center of the National Institute of Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
Children in resource-limited settings who develop illness at night are often isolated from care, resulting in progression to an emergency. A telemedicine and medication delivery service (TMDS) is a viable healthcare delivery option to bridge the gap in nighttime care. This interrupted time series study (pre/post) will evaluate a digital clinical decision-support (dCDS) tool. The objective is to assess if the tool is associated with an improvement in guideline adherence by TMDS providers.
CONDITIONS
Official Title
Improving Nighttime Access to Care and Treatment; Part 4-Haiti
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children 10 years of age or younger with an acute illness
- Parent or guardian contacts the telemedicine and medication delivery service during hours of operation
- Parent or guardian agrees to a waiver of consent documentation if contacted by phone, or provides written consent/assent during household visits (for children 7 years and older)
You will not qualify if you...
- No consent provided
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CV Foundation
Gressier, Ouest, Haiti, HT-6160
Actively Recruiting
Research Team
M
Molly B Klarman, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here